Inner pile treating orally taken medicine

Abstract

The present invention discloses one kind of inner pile treating orally taken medicine. The medicine is prepared with date and sulphur as material in certain weight ratio and through unique preparation process based on the different characteristics of the medicine materials. The medicine has the advantages of fast acting, fast hemostasis, fast healing and no recurrence.

Description

technical field [0001] The invention relates to a medicine for treating internal hemorrhoids. Specifically, it is a Chinese patent medicine prepared by special processing of traditional Chinese medicine raw materials. technical background [0002] Internal hemorrhoids take blood in stool as the main symptom, and nearly 95% of patients with internal hemorrhoids suffer from hemorrhagic anemia, and the recurrence rate of internal hemorrhoids is more than 98%, which brings great pain to patients' work, study and life. [0003] The current clinical treatment of internal hemorrhoids often encounters the following thorny problems: [0004] 1. Surgical treatment has certain risks and high recurrence rate. [0005] 2. Medication, treating the symptoms but not the root cause, commonly used to cool the blood to stop bleeding, cannot achieve a radical effect. [0006] 3. There is no western medicine specially used for the treatment of internal hemorrhoids clinically. [0007] Althou...

AI Technical Summary

Problems solved by technology

[0004] 1. Surgical treatment, with certain risks and high recurrence rate

[0005] 2. Drug treatment, treating the symptoms but not the root cause, commonly used to cool the blood to stop bleeding, will not achieve a radical effect

[0006] 3. Currently, there is no western medicine dedicated to the treatment of internal hemorrhoids clinically

[0007] Although there are some Chinese patent medicines for the treatment of hemorrhoids, they have no obvious effect on internal hemorrhoids, and they cannot be cured. In terms of treatment, one always loses sight of the other. The repeated treatment of patients is a huge financial burden, especially the recurrence of blood loss is even more miserable.